© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 3, 175-182,
February 1995
© 1995 Oxford University Press
Recent Cancer Trends in the United States
Epidemiology and Biostatistics Program, Division of Cancer Etiology Bethesda, Md
Surveillance Program, Division of Cancer Prevention and Control, National Cancer Institute Bethesda, Md
Correspondence to: Susan S. Devesa, Ph.D., Executive Plaza North, Rm. 415, National Institutes of Health, Bethesda, MD 20892-7368.
Background: Cancer incidence rates have been reported to be increasing in the United States, although trends vary according to form of cancer. Purpose: We identify the cancers accounting for the rising incidence, quantify the changes that have occurred from the mid-1970s to the early 1990s, and contrast incidence and mortality trends to provide clues to the determinants of the temporal patterns. Methods: Sex-, race-, and age-specific and age-adjusted incidence rates for the 5-year periods 1987–1991 versus 1975–1979 were calculated for 28 cancers among men and 30 cancers among women using data from the Surveillance, Epidemiology, and End Results (SEER) Program of cancer registration covering about 10% of the U.S. population. Similar rates were computed using national mortality data. Cancers were ranked according to the change in incidence rates over the two periods. Results: Age-adjusted incidence rates for all cancers combined increased by 18.6% among males and 12.4% among females from 1975–1979 to 1987–1991, due largely to rising rates for prostate cancer among men and for breast and lung cancers among women. National mortality rates for all cancers combined rose less steeply, 3% and 6% among men and women, respectively, driven mostly by continuing increases in lung cancer mortality, while death rates for the majority of the cancers were steady or declining. Total cancer incidence rose at all ages, but with different tumors responsible for the increases at different ages: leukemia and brain/nervous system cancer among children; testicular cancer, nonmelanoma skin cancer (largely Kaposi's sarcoma), non-Hodgkin's lymphoma, and melanoma among young and middle-aged adults; and prostate, breast, and lung cancers among older individuals. In contrast, mortality rates for all cancers combined declined among both males and females under age 55 years, increasing only among older persons. Conclusions: Trends in cancer incidence and mortality differ. For most cancers, incidence rates are rising, while mortality rates are generally stable or declining. Implications: Much of the recent increase in cancer incidence can be explained by known factors. Improved detection appears to account for most of the increases in breast cancer among women and prostate cancer among men. On the other hand, cigarette smoking is the major determinant of the rise in lung cancer among women, acquired immunodeficiency syndrome has led to increases in non-Hodgkin's lymphoma and Kaposi's sarcoma among young and middle-aged men, and sunlight exposure patterns have affected the trends in melanoma. Some trends remain unexplained, however, and may reflect changing exposures to carcinogens yet to be identified and clarified. [J Natl Cancer Inst 87: 175–182, 1995]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Wu, J. A. Rusiecki, K. Zhu, J. Potter, and S. S. Devesa Stomach Carcinoma Incidence Patterns in the United States by Histologic Type and Anatomic Site Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 1945 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Donnem, S. Al-Saad, K. Al-Shibli, M. P. Delghandi, M. Persson, M. N. Nilsen, L.-T. Busund, and R. M. Bremnes Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non Small Cell Lung Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6649 - 6657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xue and K. B Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Daley College Men's Knowledge, Attitudes, and Beliefs About Testicular Cancer American Journal of Men's Health, September 1, 2007; 1(3): 173 - 182. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Thieblemont and B. Coiffier Lymphoma in Older Patients J. Clin. Oncol., May 10, 2007; 25(14): 1916 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Jayaprakash, N. R. Rigual, K. B. Moysich, T. R. Loree, M. A. S. Nasca, R. J. Menezes, and M. E. Reid Chemoprevention of head and neck cancer with aspirin: a case-control study. Arch Otolaryngol Head Neck Surg, November 1, 2006; 132(11): 1231 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Landrigan, L. Trasande, L. E. Thorpe, C. Gwynn, P. J. Lioy, M. E. D'Alton, H. S. Lipkind, J. Swanson, P. D. Wadhwa, E. B. Clark, et al. The National Children's Study: A 21-Year Prospective Study of 100 000 American Children Pediatrics, November 1, 2006; 118(5): 2173 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Garolla, A Ferlin, C Vinanzi, A Roverato, G Sotti, W Artibani, and C Foresta Molecular analysis of the androgen receptor gene in testicular cancer Endocr. Relat. Cancer, September 1, 2005; 12(3): 645 - 655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Hofer, T. J. Browne, L. He, R. I. Skotheim, R. A. Lothe, and M. A. Rubin Identification of Two Molecular Groups of Seminomas by Using Expression and Tissue Microarrays Clin. Cancer Res., August 15, 2005; 11(16): 5722 - 5729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Phillips, J. Mestas, M. Gharaee-Kermani, M. D. Burdick, A. Sica, J. A. Belperio, M. P. Keane, and R. M. Strieter Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1{alpha} J. Biol. Chem., June 10, 2005; 280(23): 22473 - 22481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wan, J. Huang, N. C. Jhala, E. M. Tytler, L. Yang, S. M. Vickers, Y. Tang, C. Lu, N. Wang, and X. Cao SCF{beta}-TrCP1 Controls Smad4 Protein Stability in Pancreatic Cancer Cells Am. J. Pathol., May 1, 2005; 166(5): 1379 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Serrano, L. Baglietto, H. Johansson, F. Mariette, R. Torrisi, M. Onetto, M. Paganuzzi, and A. Decensi Effect of the Synthetic Retinoid Fenretinide on Circulating Free Prostate-Specific Antigen, Insulin-Like Growth Factor-I, and Insulin-Like Growth Factor Binding Protein-3 Levels in Men with Superficial Bladder Cancer Clin. Cancer Res., March 1, 2005; 11(5): 2083 - 2088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bertz, R. Zeiser, W. Lange, S. Fetscher, C. F. Waller, and J. Finke Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index Ann. Onc., September 1, 2004; 15(9): 1419 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Keane, J. A. Belperio, Y. Y. Xue, M. D. Burdick, and R. M. Strieter Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer J. Immunol., March 1, 2004; 172(5): 2853 - 2860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. I. Skotheim, K. S. Korkmaz, T. I. Klokk, V. M. Abeler, C. G. Korkmaz, J. M. Nesland, S. D. Fossa, R. A. Lothe, and F. Saatcioglu NKX3.1 Expression Is Lost in Testicular Germ Cell Tumors Am. J. Pathol., December 1, 2003; 163(6): 2149 - 2154. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. S. Choi, Y. M. Shim, S.-H. Kim, D. S. Son, H.-S. Lee, G. Y. Kim, J. Han, and J. Kim Prognostic significance of E-cadherin and {beta}-catenin in resected stage I non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Blayney, M. L. LeBlanc, T. Grogan, E. R. Gaynor, R. A. Chapman, C. H. Spiridonidis, S. A. Taylor, S. I. Bearman, T. P. Miller, and R. I. Fisher Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma: A Phase II Study of the Southwest Oncology Group (SWOG 9349) J. Clin. Oncol., July 1, 2003; 21(13): 2466 - 2473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Phillips, M. D. Burdick, M. Lutz, J. A. Belperio, M. P. Keane, and R. M. Strieter The Stromal Derived Factor-1/CXCL12-CXC Chemokine Receptor 4 Biological Axis in Non-Small Cell Lung Cancer Metastases Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1676 - 1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Anderko Protecting the Health of Our Nation's Children Through Environmental Health Tracking Policy Politics Nursing Practice, February 1, 2003; 4(1): 14 - 21. [Abstract] [PDF]
|
|
|
|
|
|
E. D. Crawford Intravesical Therapy for Superficial Cancer: Need for More Options J. Clin. Oncol., August 1, 2002; 20(15): 3185 - 3186. [Full Text] [PDF]
|
|
|
|
|
|
J. T. Albright, A. K. Topham, and J. S. Reilly Pediatric Head and Neck Malignancies: US Incidence and Trends Over 2 Decades Arch Otolaryngol Head Neck Surg, June 1, 2002; 128(6): 655 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Bremnes, R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin High-Throughput Tissue Microarray Analysis Used to Evaluate Biology and Prognostic Significance of the E-Cadherin Pathway in Non-Small-Cell Lung Cancer J. Clin. Oncol., May 15, 2002; 20(10): 2417 - 2428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Mariette, D. Cazals-Hatem, J. Warszawki, F. Liote, N. Balandraud, and J. Sibilia Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France Blood, May 13, 2002; 99(11): 3909 - 3915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. I. Skotheim, O. Monni, S. Mousses, S. D. Fossa, O.-P. Kallioniemi, R. A. Lothe, and A. Kallioniemi New Insights into Testicular Germ Cell Tumorigenesis from Gene Expression Profiling Cancer Res., April 1, 2002; 62(8): 2359 - 2364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. El-Naggar, S. Lai, G. L. Clayman, B. Mims, S. M. Lippman, M. Coombes, M. A. Luna, and G. Lozano p73 gene alterations and expression in primary oral and laryngeal squamous carcinomas Carcinogenesis, May 1, 2001; 22(5): 729 - 735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rodu and P. Cole The Fifty-Year Decline of Cancer in America J. Clin. Oncol., January 1, 2001; 19(1): 239 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Glantz, B. F. Cole, P. A. Forsyth, L. D. Recht, P. Y. Wen, M. C. Chamberlain, S. A. Grossman, and J. G. Cairncross Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, May 23, 2000; 54(10): 1886 - 1893. [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Smith, M. F. Denissenko, W. P. Bennett, H. Li, S. Amin, M.-s. Tang, and G. P. Pfeifer Targeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons J Natl Cancer Inst, May 17, 2000; 92(10): 803 - 811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Grauman, R. E. Tarone, S. S. Devesa, and J. F. Fraumeni Jr. Alternate Ranging Methods for Cancer Mortality Maps J Natl Cancer Inst, April 5, 2000; 92(7): 534 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Casson, S. J. Darnton, S. Subramanian, and L. Hiller What is the optimal distal resection margin for esophageal carcinoma? Ann. Thorac. Surg., January 1, 2000; 69(1): 205 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Jarvik, J. L. Stanford, E. L. Goode, R. McIndoe, S. Kolb, M. Gibbs, L. Hood, and E. A. Ostrander Confirmation of Prostate Cancer Susceptibility Genes Using High-Risk Families J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 81 - 87. [Abstract] [Full Text]
|
|
|
|
|
|
V. A. Papadimitrakopoulou, G. L. Clayman, D. M. Shin, J. N. Myers, A. M. Gillenwater, H. Goepfert, A. K. El-Naggar, J. S. Lewin, S. M. Lippman, and W. K. Hong Biochemoprevention for Dysplastic Lesions of the Upper Aerodigestive Tract Arch Otolaryngol Head Neck Surg, October 1, 1999; 125(10): 1083 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Linet, L. A. G. Ries, M. A. Smith, R. E. Tarone, and S. S. Devesa Cancer Surveillance Series: Recent Trends in Childhood Cancer Incidence and Mortality in the United States J Natl Cancer Inst, June 16, 1999; 91(12): 1051 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Devesa and J. F. Fraumeni , Jr. The Rising Incidence of Gastric Cardia Cancer J Natl Cancer Inst, May 5, 1999; 91(9): 747 - 749. [Full Text] [PDF]
|
|
|
|
|
|
F. P. Li Cancer Control in Susceptible Groups: Opportunities and Challenges J. Clin. Oncol., January 1, 1999; 17(2): 719 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Berg and B. Lindelof Is Phototherapy in Neonates a Risk Factor for Malignant Melanoma Development? A Preliminary Case-Control Study Arch Pediatr Adolesc Med, December 1, 1997; 151(12): 1185 - 1187. [Abstract] [PDF]
|
|
|
|
 |
|
 B. S. Kramer and R. D. Klausner Grappling with Cancer -- Defeatism versus the Reality of Progress N. Engl. J. Med., September 25, 1997; 337(13): 931 - 935. [Full Text]
|
|
|
|
|
|
R. J. Mayer, L. E. Schnipper, S. Broder, T.H. Hughes-Davies, T. S. Rand, P. Cole, B. Rodu, S. Corey, H. Suit, K. Isselbacher, et al. Winning the War on Cancer N. Engl. J. Med., September 25, 1997; 337(13): 935 - 938. [Full Text]
|
|
|
|
 |
|
 D.M. Winn Epidemiology of Cancer and Other Systemic Effects Associated with the Use of Smokeless Tobacco Advances in Dental Research, September 1, 1997; 11(3): 313 - 321. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Bosl and R. J. Motzer Testicular Germ-Cell Cancer N. Engl. J. Med., July 24, 1997; 337(4): 242 - 254. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Berg and B. Lindelof Differences in Malignant Melanoma Between Children and Adolescents: A 35-Year Epidemiological Study Arch Dermatol, March 1, 1997; 133(3): 295 - 297. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Irvine Is the human testis still an organ at risk? BMJ, June 22, 1996; 312(7046): 1557 - 1558. [Full Text]
|
|
|
|
 |
|
 D. Verrilli and H. G. Welch The Impact of Diagnostic Testing on Therapeutic Interventions JAMA, April 17, 1996; 275(15): 1189 - 1191. [Abstract] [PDF]
|
|